A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

IMPORTANCE: Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed. OBJECTIVE: To estimate incremental lifetime effects, costs, and co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Sun, Li, Brentnall, Adam, Patel, Shreeya, Buist, Diana S. M., Bowles, Erin J. A., Evans, D. Gareth R., Eccles, Diana, Hopper, John, Li, Shuai, Southey, Melissa, Duffy, Stephen, Cuzick, Jack, dos Santos Silva, Isabel, Miners, Alec, Sadique, Zia, Yang, Li, Legood, Rosa, Manchanda, Ranjit
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777250/
https://ncbi.nlm.nih.gov/pubmed/31580391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados